(Q33341362)

25 July 2017

title

Hepatitis B viral kinetics: a dynamic puzzle still to be resolved (English)

1 reference

25 July 2017

1 reference

1

Avidan U Neumann

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

25 July 2017

1 reference

25 July 2017

volume

42

1 reference

25 July 2017

issue

2

1 reference

25 July 2017

page(s)

249-254

1 reference

The influence of baseline characteristics on viral dynamic parameters in chronic hepatitis B patients treated with lamivudine

25 July 2017

cites work

1 reference

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

21 January 2018

1 reference

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

7 January 2021

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

7 January 2021

Decay characteristics of HIV-1-infected compartments during combination therapy

1 reference

7 January 2021

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

7 January 2021

Viral dynamics in hepatitis B virus infection

1 reference

7 January 2021

Dynamics of hepatitis B virus infection in vivo

1 reference

7 January 2021

Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy

1 reference

7 January 2021

Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: a viral dynamics study.

1 reference

7 January 2021

Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed.

1 reference

7 January 2021

Viral dynamics in chronic hepatitis B patients treated with lamivudine, lamivudine-famciclovir or lamivudine-ganciclovir.

1 reference

7 January 2021

Viral dynamics during and after entecavir therapy in patients with chronic hepatitis B.

1 reference

7 January 2021

Viral dynamics in chronic hepatitis B patients during lamivudine therapy

1 reference

7 January 2021

A viral kinetic study using pegylated interferon alfa-2b and/or lamivudine in patients with chronic hepatitis B/HBeAg negative

1 reference

7 January 2021

Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis

1 reference

7 January 2021

Second hepatitis C replication compartment indicated by viral dynamics during liver transplantation.

1 reference

7 January 2021

Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus

1 reference

7 January 2021

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

1 reference

7 January 2021

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.

1 reference

7 January 2021

Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.

1 reference

7 January 2021

Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B.

1 reference

7 January 2021

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

1 reference

7 January 2021

A dose-finding study of once-daily oral telbivudine in HBeAg-positive patients with chronic hepatitis B virus infection.

1 reference

7 January 2021

Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection.

1 reference

7 January 2021

Induction of Mx-2 in rat liver by toxic injury

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20831

1 reference

25 July 2017

1 reference